2014 Doctors Sales 
Medical Device Success
SEPTEMBER 2, 2013
If you are a medical device sales manager, are you getting the most out of your team? A Sales Plan is a good start. An end of year Sales Plan may get you that bump in sales that you need to achieve or overachieve you annual goal. Only use it if the goals the sales people offer indicate that they are hungry to achieve.
Evolve Your Success
JANUARY 2, 2024
Learn all about it from the lens of surgical tech sales with Jennifer McLaughlin. Jennifer also shares her inspiring journey in the medical sales industry, breaking down several tips on becoming an effective and relatable brand ambassador. How big are the sales teams for that type of product? I hope you enjoy this interview.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 11, 2022
Viehbacher led Sanofi between 2008 and 2014 and has decades of experience with both large pharmaceutical companies and small biotechs. However, in 2014 Sanofi fired Viehbacher over a boardroom fight regarding his management. Biogen’s shares rose 2.4% to $289.01 in pre-market trading following the announcement.
Evolve Your Success
JANUARY 23, 2024
In the changing balance between innovation and tradition, medical sales succeeds with personal connection, persistence, and the commitment to link technology and patient care. For today’s episode, we have Edouard Saget to discuss the big question: Will AI replace medical sales workforce and surgeons? Tune in to find out!
pharmaphorum
SEPTEMBER 27, 2022
Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs. That resulted in false claims for payment being submitted to the government healthcare programs Medicare and Medicaid, it alleged.
Evolve Your Success
FEBRUARY 6, 2024
Mark Copeland joins Samuel Adeyinka to share his medical sales experience in sterile processing and infection prevention. — Watch the episode here Listen to the podcast here Medical Sales In Sterile Processing And Infection Prevention With Mark Copeland We have with us another special guest and he goes by the name of Mark Copeland.
pharmaphorum
DECEMBER 29, 2022
The case revolves around allegations that Novartis made an agreement in 2011 with Par Pharmaceutical when Exforge (valsartan/amlodipine) was nearing the end of its patent life that was designed to keep Par’s generic version of the drug off the market until 30 September, 2014.
Expert insights. Personalized for you.
100 
Let's personalize your content